| [1］ Baalbergen A, Smedts F, Helmerhorst TJ.Conservative therapy in microinvasive adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a review of the literature［J］. Int J Gynecol Cancer, 2011,21(9):1640-1645. [2］ Ribeiro Cubal AF, Ferreira Carvalho JI, Costa MF, et al. Fertility-sparing surgery for early-stage cervical cancer［J］. Int J Surg Oncol, 2012,936534. [3］ Arora V, Quinn MA.Endometrial cancer［J］.Best Pract Res Clin Obstet Gynaecol, 2012 ,26(3):311-324. [4］ Morice P,Camatte S,Wickart-Poque F,et a1.Conservative management of malignant and borderline ovarian tumor［J］.Bull Cancer,2002,89(12):1019-1026． [5］ Uzan C, Kane A, Morice P,et al.Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary［J］. Ann Oncol, 2010,21(1):55-60. [6］ Rob L, Skapa P, Robova H.Fertility-sparing surgery in patientswith cervical cancer［J］.LancetOncol,2011,12:192-200. [7］ Maneo A, Sideri M, Scambia G,et al. Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervicalcancer.An Italian experience［J］. Gynecol Oncol, 2011,123(3):557-560. [8］ Dorais J, Dodson M, Calvert J, et al.Fertility-sparing management of endometrial adenocarcinoma［J］.Obstet Gynecol Surv,2011,66(7):443-451. [9］ Karimi-Zarchi M, Mousavi AS, Behtash N, et al.Conservative management of young women with endometrial carcinoma or complex atypical hyperplasia: report of three cases and literature review［J］.Eur J Gynaecol Oncol, 2011,32(6):695-698. [10］ Ramirez PT, Frumovitz M, Bodurka DC, et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review［J］.GynecolOncol,2004,95:133-138. [11］ WingoS,KnowlesL,CarrickK,et al. Retrospective cohort study of surgical staging for ovarian low malignant potentialtumors［J］. Am J Obstet Gynecol, 2006,194:e20-22. |
